QMBlog Content
Discover More:
// September 21, 2023
Ensuring Product Safety: U.S. FDA Guidance on Testing High-Risk Drug Components for D...
Excipients, or inactive ingredients, in a drug formulation are critical components, comprising up to 90% of a drug formulation by volume and serving important functions such as improving stability and increasing bioavailability for targeted drug delivery. However, with so much focus on the quality of active ingredients in the complex pharmaceutical supply chain, the quality of inactive ingredients is, at times, overlooked.
// September 21, 2023
Beyond TB medicines: How quality assurance is elevating health systems in Central Asi...
In the Kyrgyz Republic and Uzbekistan, investments in TB are resulting in broader health benefits, beyond just a single disease.
// September 15, 2023
Pharmaceutical Continuous Manufacturing: Regulatory landscape in the spotlight at USP...
The science of pharmaceutical continuous manufacturing (PCM) may not be entirely new but increasing interest in adoption of advanced manufacturing technologies (AMT) including PCM among industry and policymakers in recent years has been accompanied by strong support by FDA.
// September 15, 2023